BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Cipher Pharmaceuticals To Present At Rodman & Renshaw 16th Annual Global Investment Conference

  September 3, 2014

   · 

  1 min read
• Business

  Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak As Chairman

  September 3, 2014

   · 

  3 min read
• Business

  Nabriva Therapeutics Appoints Dr. Colin Broom As CEO

  September 3, 2014

   · 

  4 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Positive Interim Data From Phase 1/2 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis 7

  September 3, 2014

   · 

  5 min read
• Biotech Beach

  Otonomy, Inc. Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  September 3, 2014

   · 

  2 min read
• Biotech Beach

  Biocept, Inc. Strengthens Its Circulating Tumor Cell IP Position In Europe

  September 3, 2014

   · 

  3 min read
• Catalyst Pharmaceutical Partners, Inc. To Present At Rodman & Renshaw’s 16th Annual Global Investment Conference

  September 3, 2014

   · 

  3 min read
• Pharm Country

  Hemispherx Biopharma To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th

  September 3, 2014

   · 

  6 min read
• Bio NC

  Chimerix, Inc.'s Brincidofovir Selected For Two Oral Presentations Highlighting Resistance Data In CMV And Adenovirus At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC)

  September 3, 2014

   · 

  2 min read
• Drug Development

  Chimerix, Inc.'s Brincidofovir Has In Vitro Activity Against Ebola

  September 3, 2014

   · 

  3 min read